Results 201 to 210 of about 19,406,112 (259)

Therapists' and patients' experiences with electronic patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) before and during treatment in community mental health services: a qualitative study in Norway. [PDF]

BMC Psychiatry
Roos E, Molden TH, Lindberg MS, Westerlund H, Johansen KJ, Havnen A.   +5 more
europepmc   +1 more source

An exploration of the Roles of Lay Mental Health Workers (Cadres) in Community Mental Health Services in Indonesia: A Qualitative Study

, 2023
Susanti H, Brooks H, Yulia I, Windarwati HD, Yuliastuti E, Hasniah H, Keliat BA.   +6 more
europepmc   +1 more source

Recent Non‐Suicidal Self‐Injury in Autistic Adolescents and Adults: Characteristics, Clinical Correlates and Suicidal Thoughts and Behaviors

Autism Research, EarlyView.
ABSTRACT Non‐suicidal self‐injury (NSSI) is prevalent among autistic adolescents and adults, yet research on its clinical characteristics, functions, and association with suicidal thoughts and behaviors (STBs) in this population remains limited. This study compared these domains between autistic adolescents and adults with and without recent NSSI.
Safaa Eldeeb, Ligia Antezana, Caitlin M. Conner, Kelly B. Beck, Sarah E. Victor, Aliona Tsypes, Lori N. Scott, Carla A. Mazefsky   +7 more
wiley   +1 more source

The process and perspective of serious incident investigations in adult community mental health services: integrative review and synthesis. [PDF]

BJPsych Bull
Haylor H, Sparkes T, Armitage G, Dawson-Jones M, Double K, Edwards L.   +5 more
europepmc   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source

What Works, for Whom, in What Circumstances and Why, When Integrating Voluntary and Statutory Community Mental Health Services: A Realist Evaluation Case Study. [PDF]

Int J Integr Care
Hobson-Merrett C, Hardwick R, Yeandle J, Wardle B, Connor C, Gibson J, Pinfold V, Stirzaker A, Byng R.   +8 more
europepmc   +1 more source

Exploring new avenues: Psychedelic‐assisted therapy for young people

British Journal of Clinical Pharmacology, EarlyView.
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou, Dasha Nicholls, David J. Nutt, Martina Di Simplicio   +3 more
wiley   +1 more source

Predicting anxiety treatment outcome in community mental health services using linked health administrative data. [PDF]

Sci Rep
Chai KEK, Graham-Schmidt K, Lee CMY, Rock D, Coleman M, Betts KS, Robinson S, McEvoy PM.   +7 more
europepmc   +1 more source

The quantification and epistemology of medicines use and polypharmacy tested in an observational study

British Journal of Clinical Pharmacology, EarlyView.
Definitions of ‘medicines use’ and ‘polypharmacy’ may refer to all medicines, regular long‐term medicines or another subset. Valid definitions of medicines use should incorporate type of use (long term, short course and as needed [PRN]), changes in use (start, stop and dose change) and a description of temporal examination (cross‐sectional or ...
Lorna Pairman, Paul Chin, Matthew Doogue
wiley   +1 more source

Improving the Monitoring and Management of Clozapine-Induced Gastrointestinal Hypomotility (CIGH) in Community Mental Health Services: A Quality Improvement Approach. [PDF]

Pharmacy (Basel)
Adam B, Ayad O.
europepmc   +1 more source